5,412 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
General Mills (GIS) Rises As Market Takes a Dip: Key Facts https://www.zacks.com/stock/news/2193273/general-mills-gis-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2193273 Dec 04, 2023 - The latest trading day saw General Mills (GIS) settling at $64.95, representing a +1.28% change from its previous close.
Franklin Covey (FC) Rises As Market Takes a Dip: Key Facts https://www.zacks.com/stock/news/2193264/franklin-covey-fc-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2193264 Dec 04, 2023 - In the latest trading session, Franklin Covey (FC) closed at $39.54, marking a +0.61% move from the previous day.
United Airlines (UAL) Rises As Market Takes a Dip: Key Facts https://www.zacks.com/stock/news/2193248/united-airlines-ual-rises-as-market-takes-a-dip-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2193248 Dec 04, 2023 - United Airlines (UAL) reachead $40.52 at the closing of the latest trading day, reflecting a +0.7% change compared to its last close.
Unlocking Q1 Potential of Vail Resorts (MTN): Exploring Wall Street Estimates for Key Metrics https://www.zacks.com/stock/news/2193155/unlocking-q1-potential-of-vail-resorts-mtn-exploring-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2193155 Dec 04, 2023 - Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Vail Resorts (MTN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended October 2023.
Countdown to Ciena (CIEN) Q4 Earnings: Wall Street Forecasts for Key Metrics https://www.zacks.com/stock/news/2193059/countdown-to-ciena-cien-q4-earnings-wall-street-forecasts-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2193059 Dec 04, 2023 - Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Ciena (CIEN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended October 2023.
Wall Street's Insights Into Key Metrics Ahead of Lululemon (LULU) Q3 Earnings https://www.zacks.com/stock/news/2193056/wall-street-s-insights-into-key-metrics-ahead-of-lululemon-lulu-q3-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2193056 Dec 04, 2023 - Beyond analysts' top -and-bottom-line estimates for Lululemon (LULU), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended October 2023.
Northrim BanCorp (NRIM)'s Technical Outlook is Bright After Key Golden Cross https://www.zacks.com/stock/news/2192994/northrim-bancorp-nrim-s-technical-outlook-is-bright-after-key-golden-cross?cid=CS-ZC-FT-tale_of_the_tape|golden_crossover-2192994 Dec 04, 2023 - When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
Compared to Estimates, Carvana (CVNA) Q3 Earnings: A Look at Key Metrics https://www.zacks.com/stock/news/2192928/compared-to-estimates-carvana-cvna-q3-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2192928 Dec 04, 2023 - The headline numbers for Carvana (CVNA) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Compared to Estimates, Okta (OKTA) Q3 Earnings: A Look at Key Metrics https://www.zacks.com/stock/news/2192929/compared-to-estimates-okta-okta-q3-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2192929 Dec 04, 2023 - The headline numbers for Okta (OKTA) give insight into how the company performed in the quarter ended October 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
AbbVie: 4 Hidden Keys Investors Must Know To Judge ImmunoGen Acquisition https://seekingalpha.com/article/4655595-abbvie-4-hidden-keys-investors-must-know-to-judge-immunogen-acquisition?source=feed_all_articles Dec 03, 2023 - AbbVie has agreed to acquire ImmunoGen for $10 billion, nearly double its previous trading price. Read more about ABBV stock here.
<<<Page 539>